Brinker Capital Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.41M Buy
4,309
+452
+12% +$147K 0.01% 987
2025
Q1
$1.04M Buy
3,857
+113
+3% +$30.5K 0.01% 1062
2024
Q4
$881K Buy
3,744
+203
+6% +$47.8K 0.01% 1122
2024
Q3
$974K Buy
3,541
+457
+15% +$126K 0.01% 1049
2024
Q2
$749K Buy
3,084
+939
+44% +$228K 0.01% 1114
2024
Q1
$321K Sell
2,145
-384
-15% -$57.4K ﹤0.01% 1436
2023
Q4
$498K Sell
2,529
-56
-2% -$11K 0.01% 1212
2023
Q3
$458K Buy
2,585
+229
+10% +$40.6K 0.01% 1232
2023
Q2
$447K Sell
2,356
-128
-5% -$24.3K ﹤0.01% 1252
2023
Q1
$498K Sell
2,484
-28
-1% -$5.61K 0.01% 1142
2022
Q4
$597K Sell
2,512
-141
-5% -$33.5K 0.01% 918
2022
Q3
$531K Buy
2,653
+160
+6% +$32K 0.01% 928
2022
Q2
$364K Sell
2,493
-281
-10% -$41K 0.01% 1091
2022
Q1
$453K Sell
2,774
-48
-2% -$7.84K 0.01% 1084
2021
Q4
$479K Buy
2,822
+349
+14% +$59.2K 0.01% 1067
2021
Q3
$419K Hold
2,473
0.01% 1031
2021
Q2
$419K Buy
2,473
+558
+29% +$94.5K 0.01% 1090
2021
Q1
$270K Buy
+1,915
New +$270K ﹤0.01% 1079
2020
Q1
Sell
-600
Closed -$69K 318
2019
Q4
$69K Hold
600
﹤0.01% 389
2019
Q3
$48K Hold
600
﹤0.01% 433
2019
Q2
$44K Hold
600
﹤0.01% 604
2019
Q1
$56K Sell
600
-540
-47% -$50.4K ﹤0.01% 455
2018
Q4
$83K Hold
1,140
﹤0.01% 357
2018
Q3
$100K Hold
1,140
﹤0.01% 323
2018
Q2
$112K Hold
1,140
﹤0.01% 326
2018
Q1
$136K Buy
+1,140
New +$136K ﹤0.01% 302
2015
Q3
Sell
-37
Closed -$4K 453
2015
Q2
$4K Buy
+37
New +$4K ﹤0.01% 394